Literature DB >> 26435066

Guiding dengue vaccine development using knowledge gained from the success of the yellow fever vaccine.

Huabin Liang1, Min Lee1, Xia Jin1.   

Abstract

Flaviviruses comprise approximately 70 closely related RNA viruses. These include several mosquito-borne pathogens, such as yellow fever virus (YFV), dengue virus (DENV), and Japanese encephalitis virus (JEV), which can cause significant human diseases and thus are of great medical importance. Vaccines against both YFV and JEV have been used successfully in humans for decades; however, the development of a DENV vaccine has encountered considerable obstacles. Here, we review the protective immune responses elicited by the vaccine against YFV to provide some insights into the development of a protective DENV vaccine.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26435066      PMCID： PMC4711684          DOI： 10.1038/cmi.2015.76

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


  123 in total

1.  Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells.

Authors:  J M Mackenzie; M K Jones; E G Westaway
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Toll-like receptors control activation of adaptive immune responses.

Authors:  M Schnare; G M Barton; A C Holt; K Takeda; S Akira; R Medzhitov
Journal:  Nat Immunol       Date:  2001-10       Impact factor: 25.606

Review 3.  NK cells at the interface between innate and adaptive immunity.

Authors:  A Moretta; E Marcenaro; S Parolini; G Ferlazzo; L Moretta
Journal:  Cell Death Differ       Date:  2007-06-01       Impact factor: 15.828

4.  Transovarial transmission of Japanese encephalitis virus by mosquitoes.

Authors:  L Rosen; R B Tesh; J C Lien; J H Cross
Journal:  Science       Date:  1978-02-24       Impact factor: 47.728

5.  Proteins C and NS4B of the flavivirus Kunjin translocate independently into the nucleus.

Authors:  E G Westaway; A A Khromykh; M T Kenney; J M Mackenzie; M K Jones
Journal:  Virology       Date:  1997-07-21       Impact factor: 3.616

6.  Transovarial transmission of yellow fever virus by mosquitoes (Aedes aegypti).

Authors:  T H Aitken; R B Tesh; B J Beaty; L Rosen
Journal:  Am J Trop Med Hyg       Date:  1979-01       Impact factor: 2.345

7.  Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NS1 protects against lethal dengue virus encephalitis.

Authors:  B Falgout; M Bray; J J Schlesinger; C J Lai
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  The yellow fever virus vaccine induces a broad and polyfunctional human memory CD8+ T cell response.

Authors:  Rama S Akondy; Nathan D Monson; Joseph D Miller; Srilatha Edupuganti; Dirk Teuwen; Hong Wu; Farah Quyyumi; Seema Garg; John D Altman; Carlos Del Rio; Harry L Keyserling; Alexander Ploss; Charles M Rice; Walter A Orenstein; Mark J Mulligan; Rafi Ahmed
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

9.  Safety and immunogenicity of a tetravalent live-attenuated dengue vaccine in flavivirus naive children.

Authors:  Sriluck Simasathien; Stephen J Thomas; Veerachai Watanaveeradej; Ananda Nisalak; Célia Barberousse; Bruce L Innis; Wellington Sun; J Robert Putnak; Kenneth H Eckels; Yanee Hutagalung; Robert V Gibbons; Chunlin Zhang; Rafael De La Barrera; Richard G Jarman; Wipa Chawachalasai; Mammen P Mammen
Journal:  Am J Trop Med Hyg       Date:  2008-03       Impact factor: 2.345

Review 10.  Immunity to viruses: learning from successful human vaccines.

Authors:  Bali Pulendran; Jason Z Oh; Helder I Nakaya; Rajesh Ravindran; Dmitri A Kazmin
Journal:  Immunol Rev       Date:  2013-09       Impact factor: 12.988
View more
  12 in total

1.  Viral immunology: reunion of the conjoined twins disciplines.

Authors:  Chi-Chiang Yang
Journal:  Cell Mol Immunol       Date:  2016-01-04       Impact factor: 11.530

2.  Non-coding RNA: a key regulator of the pathogenicity and immunity of Flaviviridae viruses infection.

Authors:  Zhiyi Zhang; Lifang Jiang; Gucheng Zeng
Journal:  Cell Mol Immunol       Date:  2017-10-09       Impact factor: 11.530

Review 3.  Vaccinations for Neuroinfectious Disease: A Global Health Priority.

Authors:  Emily C Leibovitch; Steven Jacobson
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

4.  Semi-field evaluation of the exposure-free mosquito electrocuting trap and BG-Sentinel trap as an alternative to the human landing catch for measuring the efficacy of transfluthrin emanators against Aedes aegypti.

Authors:  Mgeni M Tambwe; Adam Saddler; Ummi Abdul Kibondo; Rajabu Mashauri; Katharina S Kreppel; Nicodem J Govella; Sarah J Moore
Journal:  Parasit Vectors       Date:  2021-05-20       Impact factor: 3.876

Review 5.  Animal models for dengue vaccine development and testing.

Authors:  Woonsung Na; Minjoo Yeom; Il-Kyu Choi; Heejun Yook; Daesub Song
Journal:  Clin Exp Vaccine Res       Date:  2017-07-26

Review 6.  Preventive and therapeutic challenges in combating Zika virus infection: are we getting any closer?

Authors:  Meera V Singh; Emily A Weber; Vir B Singh; Nicole E Stirpe; Sanjay B Maggirwar
Journal:  J Neurovirol       Date:  2017-01-23       Impact factor: 2.643

7.  Polytopic vaccination with a live-attenuated dengue vaccine enhances B-cell and T-cell activation, but not neutralizing antibodies.

Authors:  Taweewun Hunsawong; Sineewanlaya Wichit; Thipwipha Phonpakobsin; Yongyuth Poolpanichupatam; Chonticha Klungthong; Napaporn Latthiwongsakorn; Butsaya Thaisomboonsuk; Rawiwan Im-Erbsin; In-Kyu Yoon; Damon W Ellison; Louis R Macareo; Anon Srikiatkhachorn; Robert V Gibbons; Stefan Fernandez
Journal:  Heliyon       Date:  2017-03-21

8.  Meeting report: the 4th symposium on animal models of non-human primates in Kunming, Yunnan, China.

Authors:  Jia-Li Li; Yong-Tang Zheng; Xu-Dong Zhao; Xin-Tian Hu
Journal:  Zool Res       Date:  2016-11-18

9.  Phylogenomic analysis unravels evolution of yellow fever virus within hosts.

Authors:  Chen Chen; Dong Jiang; Ming Ni; Jing Li; Zhihai Chen; Jingyuan Liu; Hanhui Ye; Gary Wong; Wei Li; Yuanyuan Zhang; Beibei Wang; Yuhai Bi; Danying Chen; Ping Zhang; Xuesen Zhao; Yaxian Kong; Weifeng Shi; Pengcheng Du; Gengfu Xiao; Juncai Ma; George F Gao; Jie Cui; Fujie Zhang; Wenjun Liu; Xiaochen Bo; Ang Li; Hui Zeng; Di Liu
Journal:  PLoS Negl Trop Dis       Date:  2018-09-06

10.  Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.

Authors:  Martin R Gaudinski; Katherine V Houser; Kaitlyn M Morabito; Zonghui Hu; Galina Yamshchikov; Ro Shauna Rothwell; Nina Berkowitz; Floreliz Mendoza; Jamie G Saunders; Laura Novik; Cynthia S Hendel; LaSonji A Holman; Ingelise J Gordon; Josephine H Cox; Srilatha Edupuganti; Monica A McArthur; Nadine G Rouphael; Kirsten E Lyke; Ginny E Cummings; Sandra Sitar; Robert T Bailer; Bryant M Foreman; Katherine Burgomaster; Rebecca S Pelc; David N Gordon; Christina R DeMaso; Kimberly A Dowd; Carolyn Laurencot; Richard M Schwartz; John R Mascola; Barney S Graham; Theodore C Pierson; Julie E Ledgerwood; Grace L Chen
Journal:  Lancet       Date:  2017-12-05       Impact factor: 202.731
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.